Oxford vaccine back in the final trial
The corona vaccine, invented by researchers at Oxford University in the United Kingdom, was suspended due to adverse reactions after application. However, it is back in the final round of trials.
The Medicine Health Regulatory Agency (MHRA) has confirmed the re-trial to Reuters.
Oxford authorities said in a statement that Oxford's coronavirus vaccine would undergo clinical trials across the UK.
Earlier, trials of the third and final phase of the corona vaccine, invented by researchers at Oxford University in the United Kingdom, were temporarily suspended due to adverse reactions after application. The inventors decided to postpone the trial when one of the volunteers participating in the final round fell ill.
The Oxford vaccine came in the third phase after successfully completing the first and second phase trials. But at this stage the problem arises. The vaccine has been administered to 30,000 people in different countries. Depending on its success, this drug will be released in the market.